Furthermore, we found that IMP3 expression was significantly associated with the stage and survival of localized CCRCC patients using tissue microarray, indicating that IMP3 is involved in CCRCC progression. This evidence concerns the gene IMP3 and nonpapillary renal cell carcinoma.